Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure

NCT04706130 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT04706130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04706130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Completed
Start date
April 15, 2021
Completion date
October 1, 2024
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vivax malaria